Affibody AB
556665-6913ActiveDeveloping next-generation radiopharmaceuticals using proprietary Affibody technology.
Biotechnology Companyaffibody.se
Oversikt
- 50–99
- Ansatte
- 20–50mill SEK
- Omsetning
- 2004
- Grunnlagt
Nøkkelbeslutningstakere
Peter Zerhouni
Chief Financial Officer & Chief Business Officer
+46706XXXXXX
David Bejker
Chief Executive Officer
+46706XXXXXX
Mathias Uhlén
Board Director
Anders Martin-Löf
Board Director
+10 flere kontakter i Funnelfeedr
Beskrivelse
Affibody is a specialized biotechnology company focused on creating next-generation radiopharmaceuticals. They leverage their proprietary Affibody® platform to develop radioligand therapeutics (RLTs) designed for precision targeting. The company strategically focuses its pipeline on major cancer typ...